Motley Fool Australia

Why Fisher & Paykel Healthcare, Mesoblast, Splitit, & WiseTech are dropping lower

finger selecting sad face from choice of happy, sad and neutral faces on screen
Image source: Getty Images

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to record a solid gain. At the time of writing the benchmark index is up 0.4% to 6,616.2 points.

Four shares that have failed to follow the market higher today are listed below. Here’s why they are dropping lower:

Fisher & Paykel Healthcare Corp Ltd (ASX: FPH)

The Fisher & Paykel Healthcare share price is down 2.5% to $32.09. This appears to have been driven partly by the medical device company’s shares trading ex-dividend this morning. Eligible shareholders can now look forward to being paid its 15.2 cents per share dividend in a couple of weeks on 16 December.

Mesoblast limited (ASX: MSB)

The Mesoblast share price is down 3% to $4.29. Investors may be taking profit after a strong gain on Wednesday following the release of another positive update. That update was related to its remestemcel-L product and revealed that the United States Food and Drug Administration has granted it Fast Track designation in the treatment of acute respiratory distress syndrome (ARDS) due to COVID-19 infection.

Splitit Ltd (ASX: SPT)

The Splitit share price is down over 2.5% to $1.28. This morning the buy now pay later provider released its November update and revealed record merchant sales volume (MSV) during the Black Friday and Cyber Monday promotional period. Over the shopping event, the company reported MSV of US$15.3 million. This was an increase of 216% on the same period a year earlier. This strong finish to the month led to the company reporting year-on-year November MSV growth of 255%. Investors appear to have been expecting even stronger growth.

WiseTech Global Ltd (ASX: WTC)

The WiseTech Global share price is down 1.5% to $30.41 on the day of its investor day event. This is despite the company reaffirming its guidance for revenue of $470 million to $510 million and earnings before interest, taxes, depreciation and amortisation (EBITDA) of $155 million to $180 million. The latter represents year on year growth of 22% to 42%.

This Tiny ASX Stock Could Be the Next Afterpay

One little-known Australian IPO has doubled in value since January, and renowned Australian Moonshot stock picker Anirban Mahanti sees a potential millionaire-maker in waiting...

Because 'Doc' Mahanti believes this fast-growing company has all the hallmarks of genuine Moonshot potential, forget 'buy now pay later', this stock could be the next hot stock on the ASX.

Doc and his team have published a detailed report on this tiny ASX stock. Find out how you can access what could be the NEXT Afterpay today!

Returns as of 6th October 2020

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of WiseTech Global. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Related Articles…

Latest posts by James Mickleboro (see all)